Scinovex
review Open AccessTop 10% cited

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Nature Reviews Microbiology · 2009 · Vol. 7(3) · pp. 226–236
Lanying DuYuxian HeYusen ZhouShuwen LiuBo-Jian ZhengShibo Jiang
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research StudiesCoronavirusVirologyBiologyOutbreakImmunityProtein subunitSpike ProteinPopulationAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

MeSH terms

Viral VaccinesRNA InterferenceRNA, Small InterferingSevere Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirusVirus InternalizationSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2AnimalsAntibodies, MonoclonalAntiviral AgentsHumansPeptidyl-Dipeptidase AMembrane GlycoproteinsViral Envelope Proteins

Funding

  • Food and Health Bureau
  • National Institutes of Health
Citations
1,765
FWCI
6.68
field-weighted impact
References
145
Percentile
97%
vs. same field & year
Citations per year
Cited by
Coronavirus Disease 2019–COVID-19
Clinical Microbiology Reviews · 2020 · 1,850 citations
The SARS-CoV-2 main protease as drug target
Bioorganic & Medicinal Chemistry Letters · 2020 · 785 citations
Immunology of COVID-19: Current State of the Science
Immunity · 2020 · 1,775 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.